| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/23/2010 | US7666631 Adenosylmethionine synthetase from streptomyces sp., gene sequences coding the same and method for mass production of secondary metabolites including antibiotics thereof |
| 02/23/2010 | US7666628 Preparation of heterologous proteins on oil bodies |
| 02/23/2010 | US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi) |
| 02/23/2010 | US7666625 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 02/23/2010 | US7666622 Nucleic acid encoding monomeric fusion polypeptide R1-M-L-M, wherein R1 is a ligand-binding domain of an interleukin receptor capable of binding an interleukin target ligand, M is a self-associating component, and L is a linker; therapy for cancer or diabetic retinopathy |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666616 Expression vector comprising reporter enzyme for enhanced expression in microorganism; improving heterologouus gene expression in host cells |
| 02/23/2010 | US7666613 psychiatric disorders; serine protease; genetic engineering; schizophrenia |
| 02/23/2010 | US7666610 Expressing transporters on viral envelopes |
| 02/23/2010 | US7666582 Immunoglobulin G-degrading enzyme for use as tool in diagnosis, prevention and treatment of streptococcal infection |
| 02/23/2010 | US7666581 Complexing antigenic proteins/peptides; membrane proteins; tumor associated antigens |
| 02/23/2010 | US7666441 Nucleic acids encoding peptides having at least one biological activity of Can f I or Can f II, protein allergens of the species Canis familiaris; suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander |
| 02/23/2010 | US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666425 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666420 Composition for treating pathology associated with MSRV/HERV-W |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666414 Using modified anti-PSMA antibodies, or fragments thereof, to bind to human PSMA with high affinity and specificity; can be used as diagnostic, prophylactic, or therapeutic agents in vivo and in vitro |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3 |
| 02/23/2010 | CA2294760C Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 02/23/2010 | CA2198899C Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/23/2010 | CA2125449C Vector and mammalian cell line having improved productivity |
| 02/18/2010 | WO2010019882A1 Genetically-engineered yeast and methods of making and using |
| 02/18/2010 | WO2010019487A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 02/18/2010 | WO2010018847A1 Recombinant protein-s composition |
| 02/18/2010 | WO2009150252A3 Process for the preparation of depeptides from cyanophycin employing the isolated pseudomonas alcaligenes dip1 cgpase cpheal |
| 02/18/2010 | WO2009148896A3 Anti-phospho-akt antibodies |
| 02/18/2010 | US20100043105 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
| 02/18/2010 | US20100043097 Brassinosteroid Regulated Kinases (BRKs) That Mediate Brassinosteroid Signal Transduction and Uses Thereof |
| 02/18/2010 | US20100041743 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 02/18/2010 | US20100041138 IL-17 homologous polypeptides and therapeutic uses thereof |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100041103 Composition and method for enhancing cell growth and cell fusion |
| 02/18/2010 | US20100041102 Antagonists of pcsk9 |
| 02/18/2010 | US20100041101 Expression system for recombinant human arginase i |
| 02/18/2010 | US20100041100 modified Trichoderma reesei Family 6 (TrCel6A) cellulase more tolerant of lignin for use in enzymatic hydrolysis of cellulose in the presence of lignin, e.g., the hydrolysis of pretreated lignocellulosic feedstocks for the production of fermentable sugars, sugar alcohols and fuel alcohol |
| 02/18/2010 | US20100041099 Cells expressing pichia cytochrome c |
| 02/18/2010 | US20100041098 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 02/18/2010 | US20100041097 Synthetic gene control region |
| 02/18/2010 | US20100041096 Carcinostatic method using BRCA1-BARD1 pathway |
| 02/18/2010 | US20100041060 Iron-regulating protein-2(irp-2) as a diagnostic for neurodegenerative disease |
| 02/18/2010 | US20100041032 Composition and methods for the detection of cripto-3 |
| 02/18/2010 | US20100040676 Polycistronic hiv vector constructs |
| 02/18/2010 | US20100040650 Virus-Like paramyxovirus particles and vaccines |
| 02/18/2010 | US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040611 Antagonists of pcsk9 |
| 02/18/2010 | US20100040610 Antagonists of pcsk9 |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040597 Thrombin mutant |
| 02/18/2010 | US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules |
| 02/18/2010 | US20100040539 Vector System |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | US20100038499 Extendable/retractable support column |
| 02/18/2010 | CA2733567A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154251A1 Expression system of recombinant proteins with enhanced yield and immunogenicity |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154246A1 Viral vector and use thereof |
| 02/17/2010 | EP2154244A1 Cell culture method using amino acid-enriched medium |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2152894A1 Human bnp immunospecific antibodies |
| 02/17/2010 | EP2152861A2 Inducible mutagenesis of target genes |
| 02/17/2010 | EP2152732A1 A modified secretion system to increase expression of polypeptides in bacteria |
| 02/17/2010 | EP2152300A1 Functional humanization of complementarity determining regions (cdrs) |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | EP1133560B1 Human parathyroid hormone modifications, preparation and use |
| 02/17/2010 | EP1071700B1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 02/17/2010 | CN101649342A Purifying method of bivalent heme polypeptide-ferrum and application thereof |
| 02/17/2010 | CN101649341A Method for extracting protein peptide from membranes of fowl eggshells |
| 02/17/2010 | CN101649340A Method for preparing human interleukin-18 |
| 02/17/2010 | CN100590196C Branched neutral amino acid transporters acting as single molecule |
| 02/17/2010 | CN100590133C Growth hormone and serum albumni recombinant fusion protein |
| 02/17/2010 | CN100590131C Methods and compounds for the targeting of protein to exosomes |
| 02/17/2010 | CN100589845C Anti-neovasculature preparations for cancer |
| 02/16/2010 | USRE41129 Cytokine zalpha11 ligand polynucleotides |
| 02/16/2010 | US7663019 Transgenic snakes and methods of making |
| 02/16/2010 | US7662936 Mass spectrometry of antibody conjugates |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662928 Anti-FcRn antibodies for treatment of auto/allo immune conditions |
| 02/16/2010 | US7662927 Reducing viral infections and increasing monocyte counts; hybridomas expressing monoclonal antibodies |
| 02/16/2010 | US7662926 Selectively bind human FcyRIIB, with little or no binding to other human Fc gamma Rs, e.g., human Fc gamma RIIA; atherosclerosis; leukocyte adhesion deficiency; rheumatoid arthritis; systemic lupus erythematosus (SLE); diabetes mellitus; multiple sclerosis; Reynaud's syndrome; autoimmune thyroiditis; |
| 02/16/2010 | US7662925 Optimized Fc variants and methods for their generation |
| 02/16/2010 | US7662769 Acetylglucosaminyl transferases; neovascularization inhibitor screening; antibodies; kits |
| 02/16/2010 | US7662642 Method for detection of specific antibodies using ubiquitin fusion proteins |
| 02/16/2010 | US7662641 using the antibodies to detect the presence of the protein; Zven is a human protein expressed in testicular tissue and peripheral blood lymphocytes; stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis; may also inhibit Wnt gene; lung tumors |
| 02/16/2010 | US7662629 Cationic peptide scaffold conjugated to a nuclear targeting peptide through a specified hydrolysis resistant chemical linkage; use in transfection i.e. nonviral gene transfer |
| 02/16/2010 | US7662624 Metal-binding therapeutic peptides |
| 02/16/2010 | US7662623 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/16/2010 | US7662620 Stem cell-derived neuron survival factor polypeptides (SDNSF) for use in prevention and treatment of cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/16/2010 | US7662607 Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |
| 02/16/2010 | US7662605 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 02/16/2010 | US7662604 Chondroitinase ABC I and methods of production |
| 02/16/2010 | US7662601 thymine-DNA glycosylase (TDG) which releases thymine bases from single stranded (ss) DNA and double stranded (ds) DNA, said TDG obtainable by modification of a uracil-DNA glycosylase (UDG), wherein said modification consists of replacing tyrosine at amino acid position 147 with a different amino acids |
| 02/16/2010 | US7662600 Modified flavin adenine dinucleotide dependent glucose dehydrogenase |